Learn GMP – Blog

Learn GMP Blog

Updates, articles, and GMP guidance.

FDA Form 483s and Inspection Observations – January 2026 Summary

Mar 02, 2026

In January 2026, the United States Food and Drug Administration (FDA) continued its focused oversight of regulated industries — particularly medical device and pharmaceutical manufacturers — through inspections that resulted in multiple Form FDA 483 issuance and subsequent enforcement activity. A Form 483 (“Inspectional Observations”) is issued at the conclusion of an FDA inspection when an investigator observes conditions that in their judgment may indicate violations of the Food, Drug, and Cosmetic Act (FD&C Act) or associated current good manufacturing practice (cGMP) requirements. The issuance of a Form 483 does not itself represent a final agency determination of violation, but it signals areas requiring corrective action and quality system improvements.

Transforming Quality Culture Through Proven Practices

Jan 19, 2026

When quality failures are seen as 'just the cost of doing business,' your organization is silently leaking profit. The true cost is often hidden, eroding margins, customer trust, and competitive edge.

8 Key Elements of Document Control Systems

Jan 19, 2026

An effective Document Control System is the backbone of any organization’s quality, compliance, and operational consistency. It ensures that the right people have access to the right documents at the right time, while maintaining integrity, traceability, and security. By reading, you’ll discover: The 8 key elements required for an effective and reliable document control system. How document control adds flexibility, ease of use and collaboration into your organization. Why document control is the central hub for the information that drives your quality system.

Best Practices for QA Oversight in Fill & Finished line

Jan 17, 2026

QA oversight in fill/finish requires a proactive, presence-based approach with real-time decision-making authority. The goal is to prevent defects rather than detect them post-production, ensuring every batch meets specifications and regulatory requirements.

current trends in FDA Form 483 observations

Jan 17, 2026

The overarching trend is a shift from simple compliance with written procedures to a focus on data integrity, data governance, and overall quality culture. The FDA is increasingly using data analytics to target inspections and is scrutinizing the effectiveness of quality systems in preventing recurring issues.

How QMS Saves Millions in Warranty Costs

Jan 04, 2026

This is an excellent example of how a focused message, backed by concrete data, can effectively market the value of a Quality Management System. Your text clearly connects the problem (spiraling costs, hindered growth) to a solution (an automated QMS) with a powerful, quantified result from a recognized brand (Trane). Here is a refined version of your text, structured for maximum impact, followed by an analysis of why it works.

How to Build Unshakeable Support for Your New QMS: A Roadmap from Consensus to Confident Implementation

Jan 04, 2026

Implementing a new Quality Management System (QMS) represents more than a technological upgrade—it’s a transformational journey that reshapes processes, culture, and outcomes. Yet even the most powerful platforms can falter without one critical component: organizational buy-in. Too often, QMS initiatives become mired in complexity, competing priorities, and executive skepticism. The path forward doesn’t begin with selecting software; it begins with building a coalition of support that spans from the quality team to the C-suite.

Top 3 Quality Management Automation Processes

Dec 25, 2025

Excellent question. Automating the right processes in Quality Management doesn't just save time—it fundamentally shifts quality from a reactive, document-centric activity to a proactive, data-driven strategic function. Here are the top 3 processes to automate to significantly improve Quality Management, moving from tactical to strategic impact.